Astorg eyes ‘wealth of opportunities’ for Thermo Fisher microbiology biz; Mid-market firms poised to back pharmacies

Discussing Astorg's plans for scaling Thermo Fisher’s microbiology business, which it agreed to buy for over $1 billion; lots of opportunities in pharmacies in the middle market, as folks from law firm Bass, Berry & Sims explain.

Financial ServicesHealthcareCommentaryPE Hub Wire